Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet aggregation defect in megakaryoblastic leukemia.

A Berrebi, E Vorst, M Shtalrid

    Acta Haematologica
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A new LC/MS method for specific determination of human systemic exposure to bisphenol A, F and S through their metabolites: Application to cord blood samples.

    Environment international·2021
    Same author

    Acute steroid myopathy: a highly overlooked entity.

    QJM : monthly journal of the Association of Physicians·2018
    Same author

    Tumor Necrosis Factor Production in B Cell Chronic Lymphocytic Leukemia.

    Leukemia & lymphoma·2016
    Same author

    Cured Multiple Myeloma Followed by Primary Malignant Lymphoma of the Lung.

    Leukemia & lymphoma·2016
    Same author

    Involvement of Interleukin-6 in the Autocrine Stimulation of Chronic Lymphocytic Leukemia B Cells by Tumor Necrosis Factor.

    Leukemia & lymphoma·2016
    Same author

    Chronic Lymphocytic Leukemia in Young Adults: Report of Six Cases Under the Age of 30 Years.

    Leukemia & lymphoma·2016
    Same journal

    Dapagliflozin in Patients with homozygous β-Thalassemia and Albuminuria.

    Acta haematologica·2026
    Same journal

    Efficacy of second-generation FLT3 inhibitors in FLT3-mutated AML: A meta-analysis of randomized controlled trials.

    Acta haematologica·2026
    Same journal

    Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study.

    Acta haematologica·2026
    Same journal

    Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.

    Acta haematologica·2026
    Same journal

    Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.

    Acta haematologica·2026
    Same journal

    COVID-19 infection in patients with follicular lymphoma and related indolent B-cell lymphomas receiving anti-CD20 monoclonal antibody maintenance therapy.

    Acta haematologica·2026
    See all related articles

    Megakaryoblastic leukemia (MKL) patients often have abnormal platelets, leading to bleeding issues. This study found reduced platelet aggregation in MKL, indicating a common platelet dysfunction (thrombocytopathy) requiring careful patient management.

    Area of Science:

    • Hematology
    • Oncology
    • Cell Biology

    Background:

    • Megakaryoblastic leukemia (MKL) is a rare form of acute myeloid leukemia.
    • Patients with MKL often exhibit hemorrhagic diathesis, characterized by bleeding symptoms like purpura, ecchymosis, and epistaxis.
    • Platelet abnormalities are frequently observed in MKL, but their functional impact requires further elucidation.

    Purpose of the Study:

    • To investigate platelet aggregation function in patients diagnosed with megakaryoblastic leukemia (MKL).
    • To correlate observed platelet morphology and granule content with aggregation defects in MKL.
    • To highlight the clinical significance of thrombocytopathy in managing MKL patients.

    Main Methods:

    • Platelet aggregation was assessed in vitro using adenosine diphosphate (ADP), adrenalin, and ristocetin as aggregating agents.

    Related Experiment Videos

  • Platelet counts and morphology were evaluated in seven MKL patients.
  • Electron microscopy was employed to examine platelet alpha-granule content.

    • Main Results:

    • All seven MKL patients presented with normal or elevated platelet counts and significant bleeding symptoms.
    • Platelet morphology was markedly abnormal, with a notable reduction or absence of alpha-granules observed via electron microscopy.
    • Reduced platelet aggregation was consistently observed across all patients when stimulated with at least one aggregating agent.

    Conclusions:

    • Megakaryoblastic leukemia is frequently associated with a functional platelet disorder, termed thrombocytopathy.
    • The observed platelet aggregation defects and morphological abnormalities underscore the clinical relevance of thrombocytopathy in MKL.
    • Understanding and accounting for MKL-associated thrombocytopathy is crucial for effective patient management and treatment strategies.